Should you buy LITS stock?
Last updated:
Based on market data through , StockInvest.us rates Mei Pharma, Inc. Common Stock (LITS) as a Sell Candidate with a technical score of -4.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 6.34%
- 3-month trend forecast Down 9.21%
- Easy Tracking In The Watchlist
Mei Pharma, Inc. Common Stock stock price ended at $0.87 on Monday, after losing 4.12%
(Market data through Aug 10, 2026)
The Mei Pharma, Inc. Common Stock stock price fell by -4.12% on the last day (Monday, 10th Aug 2026) from $0.91 to $0.87. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 8.20% from a day low at $0.85 to a day high of $0.92. The price has fallen in 7 of the last 10 days and is down by -10.9% for this period. Volume has increased on the last day by 32 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 199 thousand shares were bought and sold for approximately $173.08 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.21% during the next 3 months and, with a 90% probability hold a price between $0.612 and $0.92 at the end of this 3-month period.
LITS Signals & Forecast
There are few to no technical positive signals at the moment. The Mei Pharma, Inc. Common Stock stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.94 and $0.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 22, 2026, and so far it has fallen -15.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Mei Pharma, Inc. Common Stock gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Mei Pharma, Inc. Common Stock stock
Mei Pharma, Inc. Common Stock finds support from accumulated volume at $0.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0697 between high and low, or 8.20%. For the last week, the stock has had daily average volatility of 6.66%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LITS) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Mei Pharma, Inc. Common Stock to open at $0.88, and during the day (based on 14 day Average True Range), to move between $0.84 and $0.90, which gives a possible trading interval of +/-$0.0605 (+/-7.21%) up or down from last closing price. If Mei Pharma, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.21% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.86 (0.68%) than the resistance at $0.92 (5.73%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Mei Pharma, Inc. Common Stock stock A Buy?
Mei Pharma, Inc. Common Stock holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-4.530
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.88 ( 1.15%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LITS Performance
Trading levels for LITS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.95 | 9.16% |
| R2 | 0.92 | 6.10% |
| R1 | 0.91 | 4.21% |
| Price | 0.87 | |
| S1 | 0.85 | -1.91% |
| S2 | 0.84 | -3.80% |
| S3 | 0.81 | -6.86% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.07 | 22.97% |
| R2 | 1.04 | 18.95% |
| R1 | 0.92 | 5.73% |
| Price | 0.87 | |
| S1 | 0.86 | -0.678% |
| S2 | 0.82 | -6.22% |
| S3 | 0.749 | -13.94% |
LITS Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Nov 16, 2023 | Nov 16, 2023 | Dec 06, 2023 | $1.75 | 0% |
FAQ
Click here for our free guide on how to buy Mei Pharma, Inc. Common Stock Stock.
Buy LITS